MBII Marrone Bio Innovations Inc

Marrone Bio Innovations to Hold Webinar on Insect Pest Management in Walnuts

Marrone Bio Innovations, Inc. (MBI), (NASDAQ:MBII), a leading global provider of bio-based pest management and plant health products for the agriculture and water treatment markets, in conjunction with Western Farm Press, is conducting a webinar on walnut pest management on Tuesday April 18, 2017, 11am PT/1pm CT/2pm ET.

Insect Pest Management of Walnuts | Tuesday, April 11, 2017 | 11am PT / 1pm CT / 2pm ET

REGISTER

Join Dr. Robert Van Steenwyk as he discusses the major insect pests and management programs for walnuts.

During this one hour session, Dr. Van Steenwyk will discuss:

  • Monitoring and control using the most recent pest management practices for conventional, reduced risk
  • The use and techniques for organic insecticides
  • Annual insect pest management programs and practices

P.S. - Not able to attend? Register anyway! We'll send you a link to the webinar archive so you can view it at your own convenience.

Speaker

Dr. Robert A. Van Steenwyk

Cooperative Extension Specialist emeritus, Research Entomologist

University of California, Berkeley

Dr. Robert A. Van Steenwyk is currently a Cooperative Extension Specialist emeritus and Research Entomologist at the University of California, Berkeley. He has research and extension responsibilities for deciduous fruit, nut and vine crops for California and has an active applied research and extension program in integrated pest management with particular focus on reduced risk insecticides. Dr. Van Steenwyk received his Ph.D. in Economic Entomology with minors in Statistics and Biological Control from the University of California at Riverside in 1975. After graduation, Dr. Van Steenwyk’s research focused on pink bollworm in cotton and then later vegetable crop entomology at UCR before transferring to his current position at Berkeley in 1982. Dr. Van Steenwyk has published over 300 articles and been awarded over $7,000,000 for his research and extension programs during his career. He has served on research advisory boards for a number of California commodity boards, Exotic Pest Detection Panel for the California Dept. of Agriculture and Invasive Species Advisory Committee of the U.S. Dept. of Interior. As an international consultant for U.S. AID, Dr. Van Steenwyk developed entomological work plans for cotton, pulses and potatoes for Bangladesh. Dr. Van Steenwyk has been awarded numerous awards over his career including the Distinguished Service award for Outstanding Research and Outstanding Team for European Grapevine Moth from UC, Technology Transfer award for codling moth areawide suppression by USDA and the Cherry Man of the Year award from the cherry industry.

About Marrone Bio Innovations

Marrone Bio Innovations, Inc. (NASDAQ: MBII) strives to lead the movement to a more sustainable world through the discovery, development and promotion of biological products for pest management and plant health. Our effective and environmentally responsible solutions help customers operate more sustainably while controlling pests, improving plant health, and increasing crop yields. We have four products for agriculture on the market (Regalia®, Grandevo®, Venerate® and Majestene®), and also distribute Bio-tam 2.0® for Isagro USA in the western U.S. We market Zequanox® for invasive mussels for water markets. We also have a proprietary discovery process, a rapid development platform, and a robust pipeline of pest management and plant health product candidates. At Marrone Bio Innovations, we are dedicated to pioneering better biopesticides that support a better tomorrow for users around the globe. For more information, please visit www.marronebio.com.

EN
06/04/2017

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Marrone Bio Innovations Inc

 PRESS RELEASE

Marrone Bio Innovations, Inc. Shareholders Approve Merger Agreement wi...

Marrone Bio Innovations, Inc. Shareholders Approve Merger Agreement with Bioceres Crop Solutions Corp. RALEIGH, N.C., July 11, 2022 (GLOBE NEWSWIRE) -- Marrone Bio Innovations, Inc. (NASDAQ: MBII) (MBI) announced that during a special shareholder meeting held on July 8, 2022, its shareholders approved a proposal to adopt the previously announced Agreement and Plan of Merger (Merger Agreement), dated as of March 16, 2022, by and among Bioceres Crop Solutions Corp. (BIOX), BCS Merger Sub, Inc., and MBI, pursuant to which MBI will be acquired by BIOX. At the special meeting, MBI’s stockholde...

 PRESS RELEASE

Marrone Bio Innovations, Inc. Reports First-Quarter 2022 Financial Res...

Marrone Bio Innovations, Inc. Reports First-Quarter 2022 Financial Results RALEIGH, N.C., May 11, 2022 (GLOBE NEWSWIRE) -- (NASDAQ: MBII), an international leader in sustainable bioprotection and plant health solutions, has provided its financial results for the first quarter ended March 31, 2022. Key results include: Higher sales of row crop products in the first quarter were somewhat offset by lower sales into specialty crop markets, which were affected by adverse weather conditions. Based on the strength of current orders, revenues in the first half are expected to increase in the ...

 PRESS RELEASE

Marrone Bio Innovations to Report First Quarter 2022 Results on Wednes...

Marrone Bio Innovations to Report First Quarter 2022 Results on Wednesday, May 11 at 4:30 p.m. Eastern Time RALEIGH, N.C., April 27, 2022 (GLOBE NEWSWIRE) -- Marrone Bio Innovations, Inc. (NASDAQ: MBII), an international leader in providing growers with sustainable bioprotection and plant health solutions to support global agricultural needs, will release financial results for the first quarter ended March 31, 2022, after market close on Wednesday, May 11, 2022. Management will host an investor conference call at 4:30 p.m. ET to discuss Marrone Bio Innovations’ first quarter financial re...

 PRESS RELEASE

Marrone Bio Innovations, Inc. Reports Fourth-Quarter and Full-Year 202...

Marrone Bio Innovations, Inc. Reports Fourth-Quarter and Full-Year 2021 Financial Results RALEIGH, N.C., March 28, 2022 (GLOBE NEWSWIRE) -- (NASDAQ: MBII), an international leader in sustainable bioprotection and plant health solutions, has provided its financial results for the fourth quarter and full year ended December 31, 2021. Key results include: Full year revenues rose 15.5%, with a 40.2% increase in the fourth quarter.Gross profit grew 19.1% and 31.5% for the full year and fourth quarter, respectively, with margins exceeding 59% in both periods.For the full year, net loss was ...

 PRESS RELEASE

Marrone Bio Expands Biological Seed Treatment Collaboration for Row Cr...

Marrone Bio Expands Biological Seed Treatment Collaboration for Row Crops Company poised for continued growth in a $6+ billion market¹ RALEIGH, N.C., March 24, 2022 (GLOBE NEWSWIRE) -- (NASDAQ: MBII), has signed an agreement with Corteva Agriscience (NYSE: CTVA) that expands the opportunity for MBI technologies to be used on seeds sold by Corteva for row crops globally. Marrone Bio currently provides seed treatment solutions to Corteva for use throughout Europe. MBI introduced biological seed treatments as a sustainable alternative to control yield-robbing pests in the United States i...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch